Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
50
-0.04%
|
-
|
|
Dec 03
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-0.22%
|
$9,768
$33.81 P/Share
|
|
Dec 03
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
649
+0.49%
|
-
|
|
Dec 01
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
46,584
-26.16%
|
$1,537,272
$33.53 P/Share
|
|
Dec 01
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
46,584
+20.74%
|
$326,088
$7.16 P/Share
|
|
Dec 01
2020
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,383
-14.76%
|
$111,639
$33.65 P/Share
|
|
Dec 01
2020
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
11,472
+33.35%
|
-
|
|
Dec 01
2020
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-5.81%
|
$24,189
$33.65 P/Share
|
|
Dec 01
2020
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,485
+10.53%
|
-
|
|
Nov 09
2020
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
2,028
-75.39%
|
$79,092
$39.0 P/Share
|
|
Nov 03
2020
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
259,207
-11.68%
|
$9,072,245
$35.06 P/Share
|
|
Oct 01
2020
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
2,282
-45.9%
|
$86,716
$38.56 P/Share
|
|
Oct 01
2020
|
Stephen P Macmillan Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+5.86%
|
-
|
|
Aug 28
2020
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
2,657
-1.48%
|
-
|